Tzu-Lung Kuo1, Ching-Heng Lin2, Rong-San Jiang1,3,4, Ting-Ting Yen1,3, Chen-Chi Wang1,3, Kai-Li Liang5,6,7. 1. Department of Otolaryngology, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 40705, Taiwan. 2. Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan. 3. Department of Medicine, National Yang-Ming Medical University, Taipei, Taiwan. 4. School of Medicine, Chung Shan Medical University, Taichung, Taiwan. 5. Department of Otolaryngology, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 40705, Taiwan. kellyliang1107@gmail.com. 6. Department of Medicine, National Yang-Ming Medical University, Taipei, Taiwan. kellyliang1107@gmail.com. 7. School of Medicine, Chung Shan Medical University, Taichung, Taiwan. kellyliang1107@gmail.com.
Abstract
PURPOSE: Head and neck cancers (HNCs) usually present a poor prognosis and cause high morbidity rates. Recent surveys have demonstrated that HNC incidence rates are still on the increase in many countries. Our study objective was to assess the end-of-life care for patients with HNCs in Taiwan. METHODS: Data was retrieved from Taiwan's National Health Insurance Research Database, where we identified patients who had been diagnosed with HNCs from January 1997 to December 2010. Each patient's annual trend of opioid use and hospice care needs, along with the distribution of place of death in the study cohort, were all analyzed. RESULTS: A total of 98,211 HNC patients diagnosed between 1997 and 2010 were eligible for this study. The majority of HNC patients died in hospital. Patients who were male, lived in capital area, had a higher income, had received palliative hospice care, and had been prescribed opioids tended to choose to die at home or in hospice wards. Both opioid prescription and hospice care have increased during the past 10 years; however, the rate of palliative hospice care remained below 50%. CONCLUSIONS: Our results demonstrate that greater efforts are needed to implement palliative care for HNC patients in Taiwan.
PURPOSE: Head and neck cancers (HNCs) usually present a poor prognosis and cause high morbidity rates. Recent surveys have demonstrated that HNC incidence rates are still on the increase in many countries. Our study objective was to assess the end-of-life care for patients with HNCs in Taiwan. METHODS: Data was retrieved from Taiwan's National Health Insurance Research Database, where we identified patients who had been diagnosed with HNCs from January 1997 to December 2010. Each patient's annual trend of opioid use and hospice care needs, along with the distribution of place of death in the study cohort, were all analyzed. RESULTS: A total of 98,211 HNC patients diagnosed between 1997 and 2010 were eligible for this study. The majority of HNC patients died in hospital. Patients who were male, lived in capital area, had a higher income, had received palliative hospice care, and had been prescribed opioids tended to choose to die at home or in hospice wards. Both opioid prescription and hospice care have increased during the past 10 years; however, the rate of palliative hospice care remained below 50%. CONCLUSIONS: Our results demonstrate that greater efforts are needed to implement palliative care for HNC patients in Taiwan.
Entities:
Keywords:
Head and neck cancer; Neoplasms; Opioid; Pain; Palliative care; Taiwan
Authors: Jimmy Yu Wai Chan; Victor Shing Howe To; Stanley Tien Sze Wong; William Ignace Wei Journal: Eur Arch Otorhinolaryngol Date: 2012-06-05 Impact factor: 2.503
Authors: Marinella P J Offerman; Jean F A Pruyn; Maarten F de Boer; Quirine C P Ledeboer; Jan J van Busschbach; Robert J Baatenburg de Jong; Lilly-Ann van der Velden Journal: Head Neck Date: 2013-12-18 Impact factor: 3.147
Authors: Jennifer W Mack; Anne Walling; Sydney Dy; Anna Liza M Antonio; John Adams; Nancy L Keating; Diana Tisnado Journal: Cancer Date: 2015-02-11 Impact factor: 6.860
Authors: Yumeng Wen; Changchuan Jiang; Holly M Koncicki; Carol R Horowitz; Richard S Cooper; Aparna Saha; Steven G Coca; Girish N Nadkarni; Lili Chan Journal: J Am Soc Nephrol Date: 2019-08-06 Impact factor: 10.121
Authors: Catriona R Mayland; Kate Ingarfield; Simon N Rogers; Paola Dey; Steven Thomas; Andrea Waylen; Sam D Leary; Miranda Pring; Katrina Hurley; Tim Waterboer; Michael Pawlita; Andy R Ness Journal: Palliat Med Date: 2020-02-27 Impact factor: 4.762
Authors: Catriona R Mayland; Qiaoling Marilyn Ho; Hannah C Doughty; Simon N Rogers; Prithvi Peddinti; Praytush Chada; Stephen Mason; Matthew Cooper; Paola Dey Journal: Palliat Med Date: 2020-10-21 Impact factor: 4.762